Annual SG&A:
$62.48M+$31.08M(+98.98%)Summary
- As of today, DYN annual SG&A is $62.48 million, with the most recent change of +$31.08 million (+98.98%) on December 31, 2024.
- During the last 3 years, DYN annual SG&A has risen by +$33.76 million (+117.57%).
- DYN annual SG&A is now at all-time high.
Performance
DYN SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$16.67M+$118.00K(+0.71%)Summary
- As of today, DYN quarterly SG&A is $16.67 million, with the most recent change of +$118.00 thousand (+0.71%) on September 30, 2025.
- Over the past year, DYN quarterly SG&A has increased by +$3.81 million (+29.66%).
- DYN quarterly SG&A is now -32.27% below its all-time high of $24.62 million, reached on March 31, 2024.
Performance
DYN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$4.48B-$423.80M(-10.46%)Summary
- As of today, DYN TTM SG&A is -$4.48 billion, with the most recent change of -$423.80 million (-10.46%) on September 30, 2025.
- Over the past year, DYN TTM SG&A has dropped by -$4.53 billion (-8089.20%).
- DYN TTM SG&A is now -22565.60% below its all-time high of -$19.75 million.
Performance
DYN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
DYN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +99.0% | +29.7% | -8089.2% |
| 3Y3 Years | +117.6% | +119.1% | -10000.0% |
| 5Y5 Years | +2142.6% | +334.1% | -10000.0% |
DYN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +121.5% | -32.3% | +139.7% | -283.6% | at low |
| 5Y | 5-Year | at high | +2142.6% | -32.3% | +334.1% | -4086.9% | at low |
| All-Time | All-Time | at high | >+9999.0% | -32.3% | +2477.0% | >-9999.0% | at low |
DYN Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $16.67M(+0.7%) | $64.46M(+6.3%) |
| Jun 2025 | - | $16.55M(+4.0%) | $60.64M(+12.7%) |
| Mar 2025 | - | $15.93M(+4.1%) | $53.79M(-13.9%) |
| Dec 2024 | $62.48M(+99.0%) | $15.30M(+19.0%) | $62.48M(+11.5%) |
| Sep 2024 | - | $12.86M(+32.6%) | $56.02M(+11.6%) |
| Jun 2024 | - | $9.70M(-60.6%) | $50.18M(+4.4%) |
| Mar 2024 | - | $24.62M(+178.4%) | $48.09M(+53.2%) |
| Dec 2023 | $31.40M(+11.3%) | $8.84M(+25.9%) | $31.40M(+6.4%) |
| Sep 2023 | - | $7.02M(-7.7%) | $29.51M(-2.0%) |
| Jun 2023 | - | $7.61M(-4.1%) | $30.10M(+5.3%) |
| Mar 2023 | - | $7.93M(+14.0%) | $28.58M(+1.4%) |
| Dec 2022 | $28.20M | $6.96M(-8.6%) | $28.20M(-8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $7.61M(+24.9%) | $30.91M(+4.6%) |
| Jun 2022 | - | $6.09M(-19.3%) | $29.55M(-0.7%) |
| Mar 2022 | - | $7.55M(-21.9%) | $29.75M(+3.6%) |
| Dec 2021 | $28.72M(+113.6%) | $9.66M(+54.4%) | $28.72M(+12.3%) |
| Sep 2021 | - | $6.26M(-0.6%) | $25.56M(+10.4%) |
| Jun 2021 | - | $6.29M(-3.3%) | $23.14M(+37.3%) |
| Mar 2021 | - | $6.51M(+0.1%) | $16.85M(+62.9%) |
| Dec 2020 | $13.45M(+382.7%) | $6.50M(+69.3%) | $10.34M(+169.3%) |
| Sep 2020 | - | $3.84M(+493.7%) | $3.84M(+493.7%) |
| Dec 2019 | $2.79M(+438.9%) | - | - |
| Sep 2019 | - | $647.00K | $647.00K |
| Dec 2018 | $517.00K | - | - |
FAQ
- What is Dyne Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. annual SG&A year-on-year change?
- What is Dyne Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Dyne Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. TTM SG&A year-on-year change?
What is Dyne Therapeutics, Inc. annual SG&A?
The current annual SG&A of DYN is $62.48M
What is the all-time high annual SG&A for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high annual SG&A is $62.48M
What is Dyne Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, DYN annual SG&A has changed by +$31.08M (+98.98%)
What is Dyne Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of DYN is $16.67M
What is the all-time high quarterly SG&A for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high quarterly SG&A is $24.62M
What is Dyne Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, DYN quarterly SG&A has changed by +$3.81M (+29.66%)
What is Dyne Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of DYN is -$4.48B
What is the all-time high TTM SG&A for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high TTM SG&A is -$19.75M
What is Dyne Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, DYN TTM SG&A has changed by -$4.53B (-8089.20%)